Gaynor C - Search Results

1

Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.

Dumont C, Mentré F, Gaynor C, Brendel K, Gesson C, Chenel M. Dumont C, et al. Among authors: gaynor c. Clin Pharmacokinet. 2013 Jan;52(1):43-57. doi: 10.1007/s40262-012-0022-9. Clin Pharmacokinet. 2013. PMID: 23212609 Free article.

2

A population approach to in vitro-in vivo correlation modelling for compounds with nonlinear kinetics.

Gaynor C, Dunne A, Costello C, Davis J. Gaynor C, et al. J Pharmacokinet Pharmacodyn. 2011 Jun;38(3):317-32. doi: 10.1007/s10928-011-9195-3. Epub 2011 Mar 16. J Pharmacokinet Pharmacodyn. 2011. PMID: 21409407

3

The effects of averaging on accuracy of IVIVC model predictions.

Gaynor C, Dunne A, Davis J. Gaynor C, et al. J Pharm Sci. 2009 Oct;98(10):3829-38. doi: 10.1002/jps.21662. J Pharm Sci. 2009. PMID: 19226628

4

A comparison of the prediction accuracy of two IVIVC modelling techniques.

Gaynor C, Dunne A, Davis J. Gaynor C, et al. J Pharm Sci. 2008 Aug;97(8):3422-32. doi: 10.1002/jps.21220. J Pharm Sci. 2008. PMID: 17990312

5

A nonlinear mixed effects IVIVC model for multi-release drug delivery systems.

Rossenu S, Gaynor C, Vermeulen A, Cleton A, Dunne A. Rossenu S, et al. Among authors: gaynor c. J Pharmacokinet Pharmacodyn. 2008 Aug;35(4):423-41. doi: 10.1007/s10928-008-9095-3. Epub 2008 Sep 9. J Pharmacokinet Pharmacodyn. 2008. PMID: 18780164

6

Changes in asthma mortality in England and Wales since 2001.

Shaw DE, Gaynor CM, Fogarty AW. Shaw DE, et al. Among authors: gaynor cm. Thorax. 2019 Dec;74(12):1174-1175. doi: 10.1136/thoraxjnl-2019-213350. Epub 2019 Sep 13. Thorax. 2019. PMID: 31519814

7

Improving prognosis for patients with hepatocellular carcinoma in Ireland 1994-2008.

Gaynor C, Iqbal M, Comber H, Deady S, McCormick PA. Gaynor C, et al. Eur J Gastroenterol Hepatol. 2017 Feb;29(2):221-224. doi: 10.1097/MEG.0000000000000756. Eur J Gastroenterol Hepatol. 2017. PMID: 27832038

8

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group. Mair G, et al. Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236. Epub 2015 Dec 9. Neurology. 2016. PMID: 26658907 Free PMC article. Clinical Trial.

9

Is Stroke Early Supported Discharge still effective in practice? A prospective comparative study.

Fisher RJ, Cobley CS, Potgieter I, Moody A, Nouri F, Gaynor C, Byrne A, Walker MF. Fisher RJ, et al. Among authors: gaynor c. Clin Rehabil. 2016 Mar;30(3):268-76. doi: 10.1177/0269215515578697. Epub 2015 Mar 31. Clin Rehabil. 2016. PMID: 25828093

10

Challenges in generating costs and utilisation rates associated with castration-resistant prostate cancer.

Bourke S, Burns RM, Gaynor C. Bourke S, et al. Among authors: gaynor c. J Mark Access Health Policy. 2014 Jul 4;2. doi: 10.3402/jmahp.v2.24072. eCollection 2014. J Mark Access Health Policy. 2014. PMID: 27226831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results